| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.29B | 27.85B | 33.02B | 31.46B | 26.60B | 21.62B |
| Gross Profit | 5.51B | 7.67B | 9.37B | 8.17B | 6.41B | 5.41B |
| EBITDA | 1.61B | 2.30B | 4.00B | 3.22B | 2.06B | 1.34B |
| Net Income | 837.34M | 1.44B | 2.44B | 1.69B | 1.43B | 4.00M |
Balance Sheet | ||||||
| Total Assets | 40.76B | 42.62B | 44.24B | 40.80B | 37.86B | 35.10B |
| Cash, Cash Equivalents and Short-Term Investments | 5.94B | 7.67B | 8.38B | 7.48B | 7.99B | 6.98B |
| Total Debt | 4.34B | 5.58B | 5.05B | 5.12B | 6.04B | 5.85B |
| Total Liabilities | 11.48B | 12.49B | 15.07B | 15.51B | 14.70B | 13.06B |
| Stockholders Equity | 29.20B | 30.05B | 29.09B | 25.23B | 23.11B | 22.00B |
Cash Flow | ||||||
| Free Cash Flow | -241.22M | 74.82M | 2.20B | 1.53B | 2.10B | 979.05M |
| Operating Cash Flow | -195.94M | 399.37M | 2.48B | 1.89B | 2.36B | 1.53B |
| Investing Cash Flow | 95.36M | 39.19M | -353.70M | -399.43M | -263.60M | -508.90M |
| Financing Cash Flow | -888.04M | -1.22B | -1.42B | -2.24B | -1.23B | -812.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥6.14T | 12.01 | ― | 4.06% | 0.40% | 8.40% | |
73 Outperform | ¥341.43B | 12.67 | ― | 2.99% | 0.31% | -11.04% | |
70 Outperform | ¥18.51B | 96.92 | ― | 5.14% | -13.63% | -74.53% | |
67 Neutral | ¥1.21T | 13.34 | 9.16% | 3.98% | -2.72% | 29.43% | |
65 Neutral | ¥3.07T | 14.08 | 7.55% | 2.22% | -3.22% | -29.63% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
51 Neutral | ¥17.07B | 0.51 | ― | 5.40% | -2.22% | 18.80% |